Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tryptophan
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II/ Phase III
Sponsor : Mitsubishi Tanabe Pharma | National Institute of Mental Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Tryptophan MRI in People With Schizophrenia and Healthy Controls
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 20, 2014
Lead Product(s) : Tryptophan
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II/ Phase III
Sponsor : Mitsubishi Tanabe Pharma | National Institute of Mental Health
Deal Size : Inapplicable
Deal Type : Inapplicable